Kamada (Israel) Performance
| KMDA Stock | ILA 2,190 29.00 1.31% |
Kamada has a performance score of 6 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.62, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Kamada's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kamada is expected to be smaller as well. Kamada right now secures a risk of 1.52%. Please verify Kamada total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if Kamada will be following its current price movements.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kamada are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kamada may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
| Begin Period Cash Flow | 70.2 M | |
| Total Cashflows From Investing Activities | -61 M |
Kamada |
Kamada Relative Risk vs. Return Landscape
If you would invest 207,700 in Kamada on August 25, 2024 and sell it today you would earn a total of 11,300 from holding Kamada or generate 5.44% return on investment over 90 days. Kamada is generating 0.1239% of daily returns and assumes 1.516% volatility on return distribution over the 90 days horizon. Simply put, 13% of stocks are less volatile than Kamada, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Kamada Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kamada's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Kamada, and traders can use it to determine the average amount a Kamada's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0818
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | KMDA | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.52 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Kamada is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kamada by adding it to a well-diversified portfolio.
Kamada Fundamentals Growth
Kamada Stock prices reflect investors' perceptions of the future prospects and financial health of Kamada, and Kamada fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kamada Stock performance.
| Return On Equity | -0.058 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 636.38 M | |||
| Shares Outstanding | 44.8 M | |||
| Price To Book | 1.13 X | |||
| Price To Sales | 5.37 X | |||
| Revenue | 103.64 M | |||
| EBITDA | 5 M | |||
| Cash And Equivalents | 104.55 M | |||
| Cash Per Share | 2.23 X | |||
| Total Debt | 17.41 M | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 3.93 X | |||
| Cash Flow From Operations | (8.82 M) | |||
| Earnings Per Share | (0.15) X | |||
| Total Asset | 318.67 M | |||
| Retained Earnings | (107 M) | |||
| Current Asset | 85 M | |||
| Current Liabilities | 27 M | |||
About Kamada Performance
By analyzing Kamada's fundamental ratios, stakeholders can gain valuable insights into Kamada's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kamada has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kamada has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. KAMADA operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 408 people.Things to note about Kamada performance evaluation
Checking the ongoing alerts about Kamada for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kamada help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 103.64 M. Net Loss for the year was (2.23 M) with profit before overhead, payroll, taxes, and interest of 30.33 M. | |
| Kamada has accumulated about 104.55 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23. | |
| Roughly 19.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Kamada's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kamada's stock is overvalued or undervalued compared to its peers.
- Examining Kamada's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kamada's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kamada's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kamada's stock. These opinions can provide insight into Kamada's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Kamada Stock analysis
When running Kamada's price analysis, check to measure Kamada's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kamada is operating at the current time. Most of Kamada's value examination focuses on studying past and present price action to predict the probability of Kamada's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kamada's price. Additionally, you may evaluate how the addition of Kamada to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |